The Price is Right? Promoting Local Production for ARVs in Sub-Saharan Africa
(2008; 4 pages)

Abstract

Affordability is a key concern of European donors who finance antiretroviral drugs (ARVs) to treat AIDS in Sub-Saharan African countries. In country manufacture of ARV drugs could favourably affect ARV access through increased affordability; however, generics are a volume based market, relying on economies of scale. The ability of Sub-Saharan African countries to reduce their prices below large-scale manufacturers in India is challenging. Additionally, these medicines must meet WHO prequalification standards. While the cost of second-line ARVs remains a concern, donors should focus resources on other components ARV access, such as the supply of human resources for health, health infrastructure and issues of sustainable financing.

 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 7, 2014